AI assistant
Climb Bio, Inc. — Director's Dealing 2021
Aug 16, 2021
33982_dirs_2021-08-16_d9cc3bcb-4620-49f3-829f-88ed6625c98a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Eliem Therapeutics, Inc. (ELYM)
CIK: 0001768446
Period of Report: 2021-08-12
Reporting Person: AI ETI LLC (10% Owner)
Reporting Person: Access Industries Holdings LLC (Affiliate of 10% Owner)
Reporting Person: ACCESS INDUSTRIES MANAGEMENT, LLC (Affiliate of 10% Owner)
Reporting Person: Blavatnik Len (Affiliate of 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-12 | Common Stock | C | 4209400 | $0.00 | Acquired | 4209400 | Direct |
| 2021-08-12 | Common Stock | P | 800000 | $12.50 | Acquired | 5009400 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-12 | Series A Redeemable Convertible Preferred Stock | $ | C | 3568375 | Disposed | Common Stock (3568375) | Direct | |
| 2021-08-12 | Series B Redeemable Convertible Preferred Stock | $ | C | 641025 | Disposed | Common Stock (641025) | Direct |
Footnotes
F1: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date.
F2: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
F3: Represents securities purchased in the Issuer's initial public offering.